<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71872">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02170090</url>
  </required_header>
  <id_info>
    <org_study_id>ACTICCA-1</org_study_id>
    <secondary_id>2012-005078-70</secondary_id>
    <secondary_id>ACTRN12615001283561</secondary_id>
    <nct_id>NCT02170090</nct_id>
  </id_info>
  <brief_title>Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer</brief_title>
  <acronym>ACTICCA-1</acronym>
  <official_title>Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Deutsche Krebshilfe e.V., Bonn (Germany)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>medac GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Research UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AGITG Australasian Gastro Intestinal Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KWF Kanker Bestrijding The Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre, prospective, randomized, controlled phase III trial designed to
      assess the clinical performance of gemcitabine with cisplatin and observation vs.
      observation alone in patients after curative intent resection of cholangiocarcinoma and
      muscle invasive gall bladder carcinoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ACTICCA-1 investigator initiated trial is funded by the Deutsche Krebshilfe (grant
      number 110215) and supported my medac. With respect to data obtained in the ABC-02 trial,
      the combination of cisplatin and gemcitabine for 24 weeks as investigational treatment was
      selected. Based on adjuvant trials in pancreatic cancer (e.g. ESPAC IV) with a comparable
      postoperative recovery time, inclusion of patients within a maximum interval of 16 weeks
      between surgery and start of CTx was chosen. Due to the different prognosis and treatment
      susceptibility of muscle invasive carcinoma, two separate cohorts for CCA and GBCA were
      included to capture the expected treatment effects. Randomization will be stratified for
      lymph node status for both cohorts and localization for CCA. The primary endpoint is DFS and
      secondary endpoints include OS, safety and tolerability of adjuvant CTx, quality of life,
      and patterns of disease recurrence. In both cohorts, randomization will be 1:1 with adjuvant
      CTx for 24 weeks and imaging every 12 weeks in the experimental arm and observation only in
      the control arm.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival (DFS)</measure>
    <time_frame>Disease free survival rate at 24 months (DFSR@24)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease free survival rate at 24 months (DFSR@24)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>84 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability (assessed by the rate of patients with adverse events according to NCI CTC AE v4.03)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function of biliodigestive anastomosis (in terms of surgical revision, requirement for PTCD)</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate and severity of biliary tract infections</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patterns of disease recurrence</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>locoregional control (assessed by the rate of patients with hepatic or locoregional recurrence)</measure>
    <time_frame>48 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <condition>Gall Bladder Carcinoma</condition>
  <arm_group>
    <arm_group_label>gemcitabine plus cisplatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chemotherapy will be administered on days 1 and 8 every 3 weeks, cisplatin (25 mg per square meter of body-surface area) and gemcitabine (1000 mg per square meter)
and Observation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation alone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Observation alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gemcitabine</intervention_name>
    <description>Gemcitabine 1000mg/m2</description>
    <arm_group_label>gemcitabine plus cisplatin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisplatin</intervention_name>
    <description>Cisplatin 25mg/m2</description>
    <arm_group_label>gemcitabine plus cisplatin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>clinical, laboratory and imaging evaluation every 3 months</description>
    <arm_group_label>gemcitabine plus cisplatin</arm_group_label>
    <arm_group_label>Observation alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        All enrolled patients will postoperatively be assessed for eligibility for the treatment
        phase. Additionally patients not previously enrolled into the trial for whatever reason
        (e.g. incidental finding during surgery) will be evaluated for eligibility.

          -  Histologically confirmed adenocarcinoma of biliary tract (intrahepatic, hilar or
             extrahepatic cholangiocarcinoma or muscle invasive gallbladder carcinoma) after
             radical surgical therapy with macroscopically complete resection (mixed tumor
             entities (HCC/CCA) are excluded)

          -  Macroscopically complete resection (R0/1) within 6 (-16) weeks before scheduled start
             of chemotherapy

          -  ECOG 0-1

          -  Age &gt;18 years

          -  Adequate hematologic function

          -  Adequate liver function

          -  Adequate renal function

          -  No active uncontrolled infection, except chronic viral hepatitis under antiviral
             therapy

          -  No concurrent treatment with other experimental drugs or other anti-cancer therapy,
             treatment in a clinical trial within 30 days prior to randomization

          -  Negative serum pregnancy test within 7 days of starting study treatment in
             pre-menopausal women and women &lt;1 year after the onset of menopause (Note: a negative
             test has to be reconfirmed by a urine test, should the 7-day window be exceeded)

        Criteria for initial study enrolment

          -  Written informed consent

          -  No prior chemotherapy for cholangiocarcinoma

          -  No previous malignancy within 3 years or concomitant malignancy, except:
             non-melanomatous skin cancer or adequately treated in situ cervical cancer

          -  No severe or uncontrolled cardiovascular disease (congestive heart failure NYHA III
             or IV, unstable angina pectoris, history of myocardial infarction in the last 3
             months, significant arrhythmia)

          -  Absence of psychiatric disorder precluding understanding of information of trial
             related topics and giving informed consent

          -  No serious underlying medical conditions (judged by the investigator), that could
             impair the ability of the patient to participate in the trial

          -  Fertile women (&lt; 1 year after last menstruation) and procreative men willing and able
             to use effective means of contraception (oral contraceptives, intrauterine
             contraceptive device, barrier method of contraception in conjunction with spermicidal
             jelly or surgically sterile)

          -  No pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Wege</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Stein</last_name>
    <phone>004940741056882</phone>
    <email>a.stein@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jun Li</last_name>
    <phone>004940741058572</phone>
    <email>j.li@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bankstown Hospital</name>
      <address>
        <city>Bankstown</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Merrett</last_name>
      <email>neil.merrett@sswahs.health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nepean Hospital Cancer Care</name>
      <address>
        <city>Kingswood</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenny Shannon, Dr</last_name>
      <email>jenny.shanon@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Deme Karikios, Dr</last_name>
      <email>deme.karikios@health.nsw.gov.au</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>N N</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Calvary Mater Newcastle</name>
      <address>
        <city>Waratah</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Bonaventura, Dr</last_name>
      <email>tony.bonaventura@calvarymater.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Townsville Hospital</name>
      <address>
        <city>Douglas</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suresh Varma, Dr</last_name>
      <email>suresh.varma@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Burge</last_name>
      <email>matthew.burge@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chris Karapetis</last_name>
      <email>c.karapetis@flinders.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy Van Hazel, Dr</last_name>
      <email>Guy.VanHazel@health.wa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rudolfstift Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Gruenberger, Prof</last_name>
      <email>tgruenberger@icloud.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Henrik Jensen, Dr</last_name>
      <email>lars.henrik.Jensen@rsyd.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Aachen</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Luedde, MD</last_name>
      <phone>0241 8035609</phone>
      <email>tluedde@ukaachen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Sinn, MD</last_name>
      <phone>030 450 55 3222</phone>
      <email>marianne.sinn@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kalff, Prof</last_name>
      <phone>0049 228 287 15327</phone>
      <email>kalff@uni-bonn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Cologne</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Center Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Folprecht, MD</last_name>
      <phone>0351 458 4794</phone>
      <email>gunnar.folprecht@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>W T Knoefel, Prof</last_name>
      <email>knoefel@uni-duesseldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kasper, MD</last_name>
      <phone>0049 201 723 2039</phone>
      <email>stefan.kasper@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolf Bechstein, Prof</last_name>
      <email>wolf.bechstein@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Brass, MD</last_name>
      <phone>0049761 270 34010</phone>
      <email>volker.brass@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Stein, MD</last_name>
      <phone>004940741056882</phone>
      <email>a.stein@uke.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arndt Vogel, Prof</last_name>
      <email>vogel.arndt@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Springfeld, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>K H Weiss</last_name>
      <email>Karl-Heinz.Weiss@med.uni-heidelberg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Saarland</name>
      <address>
        <city>Homburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Lammert, Prof</last_name>
      <email>frank.lammert@uks.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Jena</name>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Udo Lindig, MD</last_name>
      <phone>0049 3641 9324586</phone>
      <email>udo.lindig@med.uni-jena.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Becker, Prof</last_name>
      <email>thomas.becker@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johannes Gutenberg University of Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arndt Weinmann, MD</last_name>
      <email>arndt.weinmann@unimedizin-mainz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadine Schulte, MD</last_name>
      <email>nadine.schulte@umm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Munich Grosshadern</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Rentsch</last_name>
      <email>mrentsch@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Schnoy, MD</last_name>
      <email>elisabeth.schnoy@ukr.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruben Plentz, MD</last_name>
      <phone>07071 2984457</phone>
      <email>ruben.plentz@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Ulm</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Ettrich, MD</last_name>
      <email>thomas.ettrich@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>Wuerzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Kunzmann, Prof</last_name>
      <phone>0049931 201 31042</phone>
      <email>kunzmann_v@medizin.uni-wuerzburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heinz-Josef Klümpen</last_name>
      <email>h.klumpen@amc.uva.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMC Groningen Cancer Center</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G.A.P. Hospers, Prof.</last_name>
      <email>g.a.p.hospers@umcg.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith de Vos</last_name>
      <email>judith.de.vos@mumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus Medisch Centrum</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferry Eskens</last_name>
      <email>f.eskens@erasmusmc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadja Haj Mohammad, MD</last_name>
      <email>N.HajMohammad@umcutrecht.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital Birmingham</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamas Hikish, Dr</last_name>
      <email>Tamas.hikish@rbch.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bristol Haematology and Oncology Centre</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Addenbrooke's Hospital Cambridge</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pippa Corrie, Dr</last_name>
      <email>pippa.corrie@addenbrookes.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Velindre Hospital Cardiff</name>
      <address>
        <city>Cardiff</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilary Williams, Dr</last_name>
      <email>Hilary.Williams4@wales.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Western General Hospital Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beatson West of Scotland Cancer Centre Glasgow</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>James Paget University Hospitals</name>
      <address>
        <city>Gorleston</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrike Dernedde, Dr</last_name>
      <email>ulrike.dernedde@jpaget.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>May Thu Han, Dr</last_name>
      <email>maythu.han@jpaget.nhs.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal Surrey County Hospital Guildford</name>
      <address>
        <city>Guildford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tony Dhillon, Dr</last_name>
      <email>tony.dhillon@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hampshire Hospitals NHS Foundation Trust</name>
      <address>
        <city>Hampshire</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Jackson, Dr</last_name>
      <email>andrew.jackson@uhs.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Charlotte Rees, Dr</last_name>
      <email>charlotte.rees@hhft.nhs.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Huddersfield Royal Infirmary</name>
      <address>
        <city>Huddersfield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Rathbone, Dr</last_name>
      <email>emma.rathbone@cht.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Jo Dent, Dr</last_name>
      <email>jo.dent@cht.nhs.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St James's University Hospital Leeds</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hammersmith Hospital London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harpreet Wasan, Dr</last_name>
      <email>harpreet.wasan@imperial.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roopinder Gillmore, Dr</last_name>
      <email>rgillmore@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Bartholomew's Hospital London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>St Thomas's Hospital London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University College London Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Bridgewater, Prof</last_name>
      <email>j.bridgewater@ucl.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maidstone Hospital</name>
      <address>
        <city>Maidstone</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Waters, Dr</last_name>
      <email>justin.waters@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christie Hospital Manchester</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clatterbridge Cancer Centre Merseyside</name>
      <address>
        <city>Merseyside</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Palmer, Prof</last_name>
      <email>daniel.palmer@liverpool.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital Newcastle</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arvind Arora, Dr</last_name>
      <email>arvind.arora@nuh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Dhanny Gomez, Dr</last_name>
      <email>dhanny.gomez@nuh.nhs.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital Plymouth</name>
      <address>
        <city>Plymouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geoffrey Cogill, Dr</last_name>
      <email>geoffrey.cogill@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>David Sherriff, Dr</last_name>
      <email>david.sherriff@nhs.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Weston Park Hospital Sheffield</name>
      <address>
        <city>Sheffield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Darby, Dr</last_name>
      <email>suzanne.darby@sth.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Rees, Dr</last_name>
      <email>charlotte.rees@uhs.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 29, 2017</lastchanged_date>
  <firstreceived_date>June 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adjuvant chemotherapy</keyword>
  <keyword>cholangiocarcinoma</keyword>
  <keyword>muscle invasive gall bladder carcinoma</keyword>
  <keyword>translational research</keyword>
  <keyword>multidisciplinary</keyword>
  <keyword>AIO, DGAV, DGVS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Gallbladder Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gemcitabine</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
